Skip to main content
. 2023 Dec 6;13(50):35583–35591. doi: 10.1039/d3ra06790d

Mouse pharmacokinetic parameters of compounds 44 and 47.

Compound i.v.a (2 mg kg−1) p.o.b (10 mg kg−1)
AUClast (μg h mL−1) t 1/2 (h) CL (L h−1 kg−1) Vss (L kg−1) AUClast (μg h mL−1) C max (μg mL−1) t 1/2 (h) F %
44 0.77 ± 0.04 7.05 ± 1.92 2.58 ± 0.15 1.89 ± 0.31 0.94 ± 0.16 1.54 ± 0.33 5.45 ± 1.48 24
47 0.84 ± 0.11 1.69 ± 1.09 2.39 ± 0.32 3.23 ± 0.81 4.88 ± 2.07 2.88 ± 1.22 2.30 ± 0.23 116
a

Dosed at 2 mg kg−1 for i. v. administration of ICR mouse (n = 3, mean ± SD) in 5% DMSO/40% PEG400/55% DW (5 mL kg−1).

b

Dosed at 10 mg kg−1 for p. o. administration of ICR mouse (n = 3, mean ± SD) in 5% DMSO/40% PEG400/55% DW (5 mL kg−1).